bioRxivImmunologyPreprint
Proteomic signatures of the serological response to flu vaccination in a large human cohort study
S. Wu, S. Pushalkar, S. Maity, M. Pressler, J. Rendleman, B. Vitrinel, M. A. Carlock, T. Ross, H. Choi, C. Vogel
Abstract
The serological response to the influenza virus vaccine is highly heterogeneous for reasons that are not entirely clear. While the impact of demographic factors such as age, body mass index (BMI), sex, prior vaccination and titer levels are known to impact seroconversion, they only explain a fraction of the response. To identify signatures of the vaccine response, we quantified 273 proteins from serum samples of 160 flu vaccine recipients (2019-2020 season). We found that levels of proteins functioning in cholesterol transport were positively associated with seroconversion, likely linking to the known impact of BMI. When adjusting seroconversion for the demographic factors, we identified additional, unexpected signatures: proteins regulating actin cytoskeleton dynamics were significantly elevated in participants with high adjusted seroconversion. Viral strain specific analysis showed that this trend was largely driven by the H3N2 strain. Further, we identified complex associations between adjusted seroconversion and other factors: levels of proteins of the complement system associated positively with adjusted seroconversion in younger participants, while they were associated negatively in the older population. We observed the opposite trends for proteins of high density lipoprotein remodeling, transcription, and hemostasis. In sum, careful integrative modeling can extract new signatures of seroconversion from highly variable data that suggest links between the humoral response as well as immune cell communication and migration.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults
S. Avey, S. Mohanty, … S. Kleinstein·bioRxiv·Aug 1, 2019
- Defining influenza-specific B cells in vaccine responders, non-responders and influenza breakthrough infections
Łukasz Kedzierski, Ashleigh I. Holloway, … Katherine Kedzierska·bioRxiv·Mar 22, 2026
- An age-dependent reversal of the baseline-inflammation to vaccine-antibody-response relationship: a meta-analytic replication in ImmuneSignatures2 with independent influenza cohorts
Kilian Maire·bioRxiv·Jun 17, 2026
- Immune memory shapes human polyclonal antibody responses to H2N2 vaccination
Y. R. Yang, J. Han, … A. B. Ward·bioRxiv·Aug 23, 2023
- Cytokine Regulation of Human Antibody Responses to Influenza Vaccines
Guangbo Chen, Jing Guo, … Mark M. Davis·bioRxiv·Aug 7, 2025
- Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or Infection
André Nicolás León, Alesandra J. Rodriguez, … Andrew B. Ward·mBioPeer-reviewed·Feb 6, 2025